Medicare Enrolled

Dr. Morris Naus, M.D.

Gastroenterology · Delray Beach, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Speaking/Promotional
4675 LINTON BLVD, Delray Beach, FL 33445
5614955700
In practice since 2005 (20 years)
NPI: 1598751679 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Naus from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Naus? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Naus

Dr. Morris Naus is a gastroenterology in Delray Beach, FL, with 20 years in practice. Based on federal Medicare data, Dr. Naus performed 37,950 Medicare services across 2,005 unique beneficiaries.

Between the years covered by Open Payments, Dr. Naus received a total of $198,703 from 60 pharmaceutical and/or device companies across 1052 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in gastroenterology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Naus is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 0% volume in FL$ $198,703 industry payments

Medicare Practice Summary

Medicare Utilization ↗
37,950
Medicare services
Top 0% in FL for gastroenterology
2,005
Unique beneficiaries
$23
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~1,898 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Vedolizumab infusion (Entyvio)33,600$17$52
Infliximab infusion (Remicade)1,900$26$231
Office visit, established patient (20-29 min)520$64$237
Office visit, established patient (30-39 min)397$96$348
Upper GI endoscopy with biopsy277$78$1,175
Hospital follow-up visit, high complexity152$99$344
Colorectal cancer screening; colonoscopy on individual at high risk136$191$1,089
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less117$53$223
Removal of polyps or growths of large bowel using an endoscope with mechanical snare101$217$1,426
Initial hospital admission, high complexity85$145$670
New patient office visit (45-59 min)67$124$542
Blood draw (venipuncture)60$8$9
New patient office visit (30-44 min)52$80$358
Diagnostic exam of large bowel using a flexible endoscope51$144$1,491
Colonoscopy with biopsy50$143$1,497
Dilation of esophagus48$37$714
Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope43$90$982
Drug injection, under skin or into muscle43$12$81
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg42$1$5
Administration of chemotherapy into vein, 1 hour or less40$107$1,000
Removal of external hemorrhoids by rubber banding37$227$903
Office visit, established patient (10-19 min)37$44$142
Hospital follow-up visit, moderate complexity36$65$237
Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk31$196$1,077
Ultrasound scan of organ tissue for measuring elasticity14$86$340
New patient office or other outpatient visit, 15-29 minutes14$54$245
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
93.9% high complexity
1.7% medium
4.5% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$198,703
Total received (2018-2024)
Avg $28,386/year across 7 years
Top 1% in FL for gastroenterology
60
Companies
1,052
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$164,509 (82.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$33,858 (17.0%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$336 (0.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$115,398
2023
$3,525
2022
$2,942
2021
$16,729
2020
$929
2019
$21,442
2018
$37,737

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Phathom Pharmaceuticals, Inc.
$95,416
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$46,253
Celltrion USA Inc.
$17,584
Takeda Pharmaceuticals U.S.A., Inc.
$10,237
Synergy Pharmaceuticals Inc
$9,112
Otsuka America Pharmaceutical, Inc.
$3,619
ABBVIE INC.
$2,739
Allergan Inc.
$1,480
AbbVie, Inc.
$1,268
E.R. Squibb & Sons, L.L.C.
$1,168
Janssen Biotech, Inc.
$961
AbbVie Inc.
$863
Celgene Corporation
$779
PFIZER INC.
$768
Ardelyx, Inc.
$496
Ferring Pharmaceuticals Inc.
$402
Romark Laboratories, LC
$402
Cumberland Pharmaceuticals, Inc.
$381
QOL Medical, LLC
$378
Gilead Sciences, Inc.
$325
Braintree Laboratories, Inc.
$323
GENZYME CORPORATION
$305
Shire North American Group Inc
$270
UCB, Inc.
$264
RedHill Biopharma Inc.
$219
Intercept Pharmaceuticals, Inc.
$214
Merck Sharp & Dohme Corporation
$214
Pharmacosmos Therapeutics Inc.
$194
Merck Sharp & Dohme LLC
$193
Ironwood Pharmaceuticals, Inc
$188
Medtronic, Inc.
$163
Lilly USA, LLC
$160
Nestle HealthCare Nutrition Inc.
$148
Daiichi Sankyo Inc.
$120
Regeneron Healthcare Solutions, Inc.
$110
Fresenius Kabi USA, LLC
$101
NESTLE HEALTHCARE NUTRITION INC.
$100
Janssen Scientific Affairs, LLC
$94
Prometheus Laboratories Inc.
$64
Ethicon Inc.
$58
Endo Pharmaceuticals Inc.
$55
Axonics, Inc.
$55
Shionogi Inc
$46
IRONWOOD PHARMACEUTICALS, INC
$42
INTERCEPT PHARMACEUTICALS, INC.
$41
AIMMUNE THERAPEUTICS, INC.
$40
Micro-tech Endoscopy USA, Inc.
$34
EVOKE PHARMA, INC.
$31
Madrigal Pharmaceuticals
$28
Amgen Inc.
$26
VIVUS, Inc.
$24
Alnylam Pharmaceuticals Inc.
$21
Boehringer Ingelheim Pharmaceuticals, Inc.
$20
Ethicon US, LLC
$18
Covidien LP
$16
Allergan, Inc.
$16
VIVUS LLC
$16
Evoke Pharma, Inc.
$14
Lucid Diagnostics Inc.
$14
GI Supply, Inc.
$12
Top 3 companies account for 80.1% of total payments
Associated products mentioned in payments ›
ABC · ALINIA · APRISO · AVSOLA · Alinia · Alinia Tablets 500mg 30 count bottle · Amitiza · Axonics · BREATHTEK · CIMZIA · CLENPIQ · CREON · Cimzia · Creon · DIFICID · DUPIXENT · Dexilant · ENTYVIO · EOHILIA · Entyvio · Epclusa · GATTEX · GIMOTI · GIVLAARI · HUMIRA · Humira · IBSRELA · IDACIO · INFLECTRA · INJECTAFER · INTERSTIM · KRISTALOSE · Kristalose · Kristalose 20gm · LINX Reflux Management System · LINZESS · Linzess · MAVYRET · MONOFERRIC · MOTEGRITY · MOTOFEN · Mavyret · Movantik · Mulpleta · NASCOBAL · OCALIVA · OMVOH · Omeclamox · Omeclamox-Pak · PANCREAZE · PLENVU · REBYOTA · RELISTOR · REMICADE · RESMETIROM · RINVOQ · SKYRIZI · STELARA · SUCRAID · SUPREP · SUPREP BOWEL PREP · SUTAB · Small Bowel · Sucraid · SureClip · Symproic · TREMFYA · TRULANCE · Talicia · Trulance · VEGZELMA · VELSIPITY · VIBERZI · VOQUEZNA · XELJANZ · XIFAXAN · XIFAXANIBSD · XIFIXAN · YUFLYMA · ZENPEP · ZEPATIER · ZEPOSIA · ZINPLAVA · ZYMFENTRA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (83%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in gastroenterology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for gastroenterology in FL.

Equivalent to $524 per 100 Medicare services performed
Looking for a gastroenterology in Delray Beach?
Compare gastroenterologys in the Delray Beach area by procedure volume, costs, and industry payment transparency.
Browse gastroenterologys nearby

Geographic Context

Gastroenterologys within 10 mi
130
Per 100K population
8.6
County median income
$81,115
Nearest hospital
DELRAY MEDICAL CENTER
1.6 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Naus is a mixed practice specialist, with above-average Medicare volume (top 0% in FL), and high industry engagement (speaking/promotional, top 1%), with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Naus experienced with vedolizumab infusion (entyvio)?
Based on Medicare claims data, Dr. Naus performed 33,600 vedolizumab infusion (entyvio) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Naus receive payments from pharmaceutical companies?
Yes. Dr. Naus received a total of $198,703 from 60 companies across 1,052 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Naus's costs compare to other gastroenterologys in Delray Beach?
Dr. Naus's average Medicare payment per service is $23. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Naus) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →